Accretive Health Provides Updated Timeline for Completion of Restatement

Expects to File 2013 Form 10-K and Hold Business Update Call on Dec. 30

CHICAGO--()--Accretive Health, Inc. (OTC Pink: ACHI) today announced that it is in the final stages of completing its financial restatement. The Company currently expects to file its Annual Report on Form 10-K for the year ended December 31, 2013 with the Securities and Exchange Commission (SEC) after the market closes on December 30, 2014. The 2013 Form 10-K will include results for the fiscal years ended December 31, 2013 and December 31, 2012, and restated results for the fiscal year ended December 31, 2011. The company previously announced on November 12, 2014 that it expected to complete its restatement and related audits, and to file the 2013 Form 10-K by the middle of December.

Conference Call and Webcast Details

Accretive Health’s management team will host a conference call on December 30, 2014 at 3:30 p.m. CT (4:30 p.m. ET) to discuss the restatement and business outlook. To participate, please dial 877-280-4954 (857- 244-7311 from outside the U.S. and Canada) using conference code number 32430071, or visit the Investor Relations section of Accretive Health’s web site at to access the live webcast. A replay will be available for one week following the conference call at 888-286-8010 (617-801-6888 from outside the U.S. and Canada) using conference code number 46013693. A replay of the conference call will also be available online at

About Accretive Health

At Accretive Health, our mission is to partner with healthcare communities to serve as a catalyst for a healthier future for all. For more information, visit

Safe Harbor

This press release contains forward-looking statements, including the statements regarding the Company’s ability to file its Annual Report on Form 10-K for the year ended December 31, 2013. All forward-looking statements contained in this press release involve risks and uncertainties. Our actual results and outcomes could differ materially from those anticipated in these forward-looking statements as a result of various factors, including the possibility that our ongoing restatement could have unanticipated consequences and the factors set forth in the Company’s quarterly report on Form 10-Q for the quarter ended September 30, 2012, filed with the SEC on November 8, 2012, under the heading “Risk Factors”. The words “strive,” “objective,” “anticipates,” “believes,” “estimates,” “expects,” “intends,” “may,” “plans,” “projects,” “vision,” “would,” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. The Company has based these forward-looking statements on its current expectations and projections about future events. Although the Company believes that the expectations underlying any of its forward-looking statements are reasonable, these expectations may prove to be incorrect and all of these statements are subject to risks and uncertainties. Should one or more of these risks and uncertainties materialize, or should underlying assumptions, projections, or expectations prove incorrect, actual results, performance, financial condition, or events may vary materially and adversely from those anticipated, estimated, or expected.

All forward-looking statements included in this press release are expressly qualified in their entirety by these cautionary statements. The Company cautions readers not to place undue reliance on any forward-looking statement that speaks only as of the date made and to recognize that forward-looking statements are predictions of future results, which may not occur as anticipated. Actual results could differ materially from those anticipated in the forward-looking statements and from historical results, due to the uncertainties and factors described above, as well as others that the Company may consider immaterial or does not anticipate at this time. Although the Company believes that the expectations reflected in its forward-looking statements are reasonable, the Company does not know whether its expectations may prove correct. The Company’s expectations reflected in its forward-looking statements can be affected by inaccurate assumptions it might make or by known or unknown uncertainties and factors, including those described above. The risks and uncertainties described above are not exclusive, and further information concerning the Company and its business, including factors that potentially could materially affect its financial results or condition or relationships with customers and potential customers, may emerge from time to time. The Company assumes no, and it specifically disclaims any, obligation to update, amend, or clarify forward-looking statements to reflect actual results or changes in factors or assumptions affecting such forward-looking statements. The Company advises investors, however, to consult any further disclosures it makes on related subjects in our periodic reports that it files with or furnishes to the SEC.


Accretive Health, Inc.
Investor Relations:
Atif Rahim
Media Relations:
Brian Pitts

Accretive Health, Inc.